The prescribing patterns for COPD patients were often found to differ between primary care providers (PCPs) and pulmonologists, observed a recent study conducted by a team of researchers from the Department of Medicine, University of Kentucky. The researchers said that 171 physicians (including 92 PCPs and 79 pulmonologists) completed the survey to find that pulmonologists more frequently prescribed dual bronchodilation and triple therapy than PCPs. The survey also revealed that inhaled corticosteroid/long-acting β2-agonist was more frequently prescribed by PCPs than pulmonologists. The team concluded that improved physician understanding would help optimise patient care in COPD.